TRDA
Entrada Therapeutics Inc
6.20$
-4.3%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 50.7% | 1.8% | 1.6% | 1.0% | 4.6% | 2.7% | – | 56.4% | 2,376.8% | 68.2% | 92.0% | – | – | |
| 49.3% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | -2,276.8% | 31.8% | 8.0% | 100.0% | -754.7% | |
| 50.7% | 67.6% | 48.4% | 33.8% | 159.7% | 89.3% | 156.0% | 1,942.4% | 2,376.8% | 2,614.1% | 3,777.6% | 3,938.6% | 3,003.4% | |
| 17.2% | 20.7% | 15.9% | 9.8% | 51.0% | 26.4% | 50.0% | 560.1% | 638.4% | 735.2% | 1,157.0% | 1,168.4% | 863.6% | |
| 17.2% | 88.3% | 64.3% | 43.6% | 210.7% | 115.7% | 206.0% | 2,502.5% | 638.4% | 3,281.1% | 4,842.6% | 5,107.0% | 3,012.4% | |
| 32.0% | 11.7% | 35.7% | 56.4% | -110.7% | -15.7% | -106.0% | -2,402.5% | -2,915.2% | -3,249.3% | -4,834.6% | -5,007.0% | -3,767.1% | |
| – | 10.6% | – | – | – | – | – | – | – | – | – | – | – | |
| 120.9% | 22.0% | 42.8% | 61.0% | -81.2% | -2.0% | -84.4% | -2,201.3% | -2,693.9% | -3,007.9% | -4,534.7% | -4,758.1% | -3,520.3% | |
| 39.8% | 44.8% | 3.1% | 2.9% | -9.5% | -5.0% | – | 9.1% | 40.5% | 7.1% | 4.3% | 3.9% | 17.5% | |
| 81.1% | -22.8% | 39.7% | 58.1% | -71.7% | 3.0% | -84.4% | -2,210.4% | -2,734.4% | -3,014.9% | -4,539.1% | -4,762.0% | -3,537.7% | |
| 122.8% | 23.7% | 44.4% | 62.0% | -76.4% | 0.7% | -79.8% | -2,148.3% | -2,617.7% | -3,222.2% | -4,442.7% | -4,664.5% | -3,518.3% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.